Abstract
Dopamine can be released in the substantia nigra from the dendrites of nigrostriatal dopaminergic neurones, to be involved there in the self-regulation of the dopaminergic cells, to control the release of neurotransmitters from nigral afferent fibres and to influence the activity of nigral non-dopaminergic cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bjorklund, A. & Lindvall, O. Brain Res. 83, 531–537 (1975).
Hamori, J., Pasik, P. & Pasik, T. Adv. Neural. 14, 149–162 (1975).
Kreutzberg, G. W., Toth, L. & Kaiya, H. Adv. Neurol. 14, 269–282 (1975).
Ramon-Moliner, E. Adv. Neurol. 14, 135–148 (1975).
Shepherd, G. M. Scient. Am. 238, 92–102 (1978).
Juraska, J. M., Wilson, C. J. & Groves, P. M. J. comp. Neurol. 172, 585–600 (1977).
Sotelo, C. J. Ultrastruct. Res. 36, 824–841 (1971).
Parizek, J., Hassler, R. & Bak, I. J. Z. Zellforsch. mikrosk. Anat. 115, 137–148 (1971).
Cuello, A. C. & Kelly, J. S. Br. J. Pharmac. 59, P 527–528 (1977).
Cuello, A. C. & Iversen, L. L. in Interactions between Putative Neurotransmitters in the Brain (eds Garattini, S., Pujol, J. F. & Samanin, R.) 127–149 (Raven, New York, 1978).
Sotelo, C., Javoy, F., Agid, Y. & Glowinski, J. Brain Res. 58, 269–290 (1973).
Hattori, T., Fibiger, H. C. & McGeer, P. L. J. comp. Neurol. 162, 487–504 (1975).
Pickel, V. M., Joh, T. H., Field, P. M., Becker, C. G. & Reis, D. J. J. Histochem. Cytochem. 23, 1–12 (1975).
Hökfelt, T., Johansson, O., Fuxe, K., Goldstein, M. & Park, D. Medbiol. Illust. 54, 427–453 (1976).
Pickel, V. M., Joh, T. H. & Reis, D. J. J. Histochem. Cytochem. 24, 792–806 (1976).
Ljungdahl, A., Hökfelt, T., Nilsson, G. & Goldstein, M. Neuroscience 3, 945–976 (1978).
Hattori, T., McGeer, P. L. & McGeer, E. G. Brain Res. 170, 71–83 (1979).
Javoy, F., Hamon, M. & Glowinski, J. Eur. J. Pharmac. 10, 178–188 (1970).
Hornykiewicz, O. Wien. klin. Wschr. 75, 309–312 (1963).
Versteeg, D. H. G. Van der Gugten,, J., De Jong, W. & Palkovitz, M. Brain Res. 113, 563–574 (1976).
Geffen, L. B., Jessell, T. M., Cuello, A. C. & Iversen, L. L. Nature 260, 258–260 (1976).
Mercer, L., Del Fiacco, M. & Cuello, A. C. Experientia 35, 101–103 (1979).
Wilson, C. J., Groves, P. M. & Fifkova, E. Expl Brain Res. 30, 161–174 (1977).
Korf, J., Zieleman, M. & Westerink, B. H. C. Nature 260, 257–258 (1976).
Korf, J., Zieleman, M. & Westerink, B. H. C. Brain Res. 120, 184–187 (1977).
Westerink, B. H. C. J. Pharm. Pharmac. 31, 94–99 (1979).
Fadda, F., Argiolas, A., Stefanini, A. & Gessa, G. L. Life Sci. 21, 411–418 (1977).
Kebabian, J. W., Saavedra, J. M. & Axelrod, J. J. Neurochem. 28, 795–801 (1977).
Hefti, F., Lienhart, R. & Lichtensteiger, W. Nature 263, 341–343 (1976).
Pericic, D. & Walters, J. R. J. Pharm. Pharmac. 28, 527–529 (1976).
Wuerthele, S. M., Friedle, N. M. & Moore, K. E. J. Neurol. Transm. 45, 117–127 (1979).
Westerink, B. H. C. & Korf, J. Eur. J. Pharmac. 40, 131–136 (1976).
Tagerud, S. E. O. & Cuello, A. C. Neuroscience 4, 2021–2029 (1979).
Hefti, F. & Lichtensteiger, W. J. Neurochem. 30, 1217–1230 (1978).
Hefti, F. & Lichtensteiger, W. Neurosci. Lett. 10, 65–70 (1978).
Silbergeld, E. K. & Walters, J. R. Neurosci. Lett. 12, 119–126 (1979).
Paden, C., Wilson, C. J. & Groves, P. M. Life Sci. 19, 1499–1506 (1976).
Starr, M. S. Eur. J. Pharmac. 48, 325–328 (1978).
Reubi, J. C., Emson, P. C., Jessell, T. M. & Iversen, L. L. Naunyn Schmiedebergs Archs Pharmak. 304, 271–275 (1978).
Kerwin, E. & Pycock, C. Br. J. Pharmac. 64, 428 (1978).
Kerwin, E. & Pycock, C. Eur. J. Pharmac. 54, 93–98 (1979).
Nieoullon, A., Chéramy, A. & Glowinski, J. Nature 266, 375–377 (1977).
Wong, R. K. S., Prince, D. A. & Basbaum, A. I. Proc. natn. Acad. Sci. U.S.A. 76, 986–990 (1979).
Fukuda, J. & Kameyama, M. Brain Res. 182, 191–197 (1980).
Llinas, R. & Hess, R. Proc. natn. Acad. Sci. U.S.A. 7, 2520–2523 (1976).
Michelot, R., Leviel, V., Giorguieff-Chesselet, M. F., Chéramy, A. & Glowinski, J. Life Sci. 24, 715–724 (1979).
Chéramy, A., Michelot, R., Nieoullon, A., Leviel, V. & Kerdelhué, B. in Catecholamines: Basic and Clinical Frontiers Vol. 2 (eds Usdin, E., Kopin, I. J. Barchas, J.) 1098–1100 (Pergamon, New York, 1979).
Chéramy, A., Nieoullon, A. & Glowinski, J. Eur. J. Pharmac. 48, 281–295 (1979).
Nieoullon, A., Chéramy, A. & Glowinski, J. Brain Res. 145, 69–84 (1978).
Nieoullon, A., Chéramy, A. & Glowinski, J. Brain Res. 148, 143–152 (1978).
Leviel, V., Chéramy, A. & Glowinski, J. Nature 280, 236–239 (1979).
Greenfield, S., Chéramy, A., Leviel, V. & Glowinski, J. Nature 284, 355–357 (1980).
Nieoullon, A., Chéramy, A. & Glowinski, J. Nature 269, 340–342 (1977).
Bunney, B. S. & Aghajanian, G. K. Nature new Biol. 245, 123–125 (1973).
Aghajanian, G. K. & Bunney, B. S. Naunyn-Schmiedebergs Archs Pharmak. 297, 1–7 (1977).
Groves, P. M., Wilson, C. J., Young, S. J. & Rebec, G. V. Science 190, 522–529 (1975).
Groves, P. M., Young, S. J. & Wilson, C. J. Neuropharmacology 15, 755–762 (1976).
Reisine, T. D., Nagy, J. I., Fibiger, H. C. & Yamamura, H. I. Brain Res. 169, 209–214 (1979).
Quik, M., Emson, P. C. & Joyce, E. Brain Res. 167, 355–365 (1979).
Murrin, L. C., Gale, K. & Kuhar, M. J. Eur. J. Pharmac. 60, 229–235 (1979).
Nagy, J. I., Lee, T., Seeman, P. & Fibiger, H. C. Nature 274, 278–281 (1978).
Chéramy, A., Nieoullon, A., Michelot, R. & Glowinski, J. Neurosci. Lett. 4, 105–109 (1977).
Nieoullon, A., Chéramy, A., Leviel, V. & Glowinski, J. Eur. J. Pharmac. 53, 289–296 (1979).
DiChiara, G., Porceddu, M. L., Spano, P. F. & Gessa, G. L. Brain Res. 130, 374–382 (1977).
Garcia-Munoz, M., Nicolau, N. M., Tulloch, I. F., Wright, A. K. & Arbuthnott, G. W. Nature 265, 363–365 (1977).
Bunney, B. S. & Aghajanian, G. K. Naunyn-Schmiedebergs Archs Pharmak 304, 255–261 (1978).
Carlsson, A. & Lindqvist, M. Acta pharmac. tox. 20, 140–144 (1963).
Chéramy, A. et al. Brain Res. 155, 404–408 (1978).
Bunney, B. S. & Aghajanian, G. K. in The Basal Ganglia (ed. Yahr M. P.) 249–267 (Raven, New York, 1976).
Dray, A. Neuroscience 4, 1407–1439 (1979).
Reubi, J. C. & Sandri, C. Neurosci. Lett. 13, 183–188 (1979).
Prémont, J. et al. FEBS Lett. 68, 99–104 (1976).
Spano, P. F., DiChiara, G., Tonon, G. C. & Trabucchi, M. J. Neurochem. 27, 1565–1568 (1976).
Gale, K., Guidotti, A. & Costa, E. Science 195, 503–505 (1977).
Dray, A. & Straughan, D. W. J. Pharm. Pharmac. 28, 400–405 (1976).
Ruffieux, A. & Schultz, W. Nature 285, 240–241 (1980).
Brown, L. L. & Wolfson, L. I. Brain Res. 140, 188–193 (1978).
Wechsler, L. R., Savaki, H. E. & Sokoloff, I. J. Neurochem. 32, 15–22 (1979).
Reubi, J. C., Iversen, L. L. & Jessell, T. M. Nature 268, 652–654 (1977).
Van der Heyden, J. A. M., Venema, K. & Korf, J. J. Neurochem. 34, 119–125 (1980).
Jessell, T. M. Proc. int. Soc. Neurochem. 6, 220 (1977).
Chéramy, A., Chesselet, M. F., Leviel, V. & Glowinski, J. (in preparation).
Héry, F. et al. Brain Res. 193, 143–151 (1980).
Jaffé, E. H. & Cuello, A. C. (in preparation).
Kramer, S. G. Invest. Ophthalmol. 71, 438–52 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cheramy, A., Leviel, V. & Glowinski, J. Dendritic release of dopamine in the substantia nigra. Nature 289, 537–543 (1981). https://doi.org/10.1038/289537a0
Issue Date:
DOI: https://doi.org/10.1038/289537a0
This article is cited by
-
Substantia nigral dopamine transporter uptake in dementia with Lewy bodies
npj Parkinson's Disease (2023)
-
A genetically encoded sensor measures temporal oxytocin release from different neuronal compartments
Nature Biotechnology (2023)
-
Paraquat as an Environmental Risk Factor in Parkinson’s Disease Accelerates Age-Related Degeneration Via Rapid Influx of Extracellular Zn2+ into Nigral Dopaminergic Neurons
Molecular Neurobiology (2019)
-
Extracellular Zn2+ Influx into Nigral Dopaminergic Neurons Plays a Key Role for Pathogenesis of 6-Hydroxydopamine-Induced Parkinson’s Disease in Rats
Molecular Neurobiology (2019)
-
Baicalin reverses the impairment of synaptogenesis induced by dopamine burden via the stimulation of GABAAR–TrkB interaction in minimal hepatic encephalopathy
Psychopharmacology (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.